Table 1.
Characteristic | Participants (n)3 | ANOVA p-value4 | |||||||
---|---|---|---|---|---|---|---|---|---|
SW | WW | SM | WM | Characteristic | Race | Gender | Characteristic×race | Characteristic×gender | |
DM | <0.0001 | NS | <0.0001 | NS | 0.0002 | ||||
No | 113b | 208a | 126b | 98ab | |||||
Yes | 11 | 4 | 14 | 3 | |||||
OM1 | NS | 0.0002 | <0.0001 | NS | NS | ||||
No | 103 | 173 | 102 | 81 | |||||
Yes | 21 | 39 | 38 | 20 | |||||
CD2 | NS | 0.01 | 0.001 | NS | NS | ||||
No | 115 | 201 | 128 | 91 | |||||
Yes | 9 | 11 | 12 | 10 |
Taking one or more of the following medications: amlodipine/atorvastatin, atorvastatin, calcium channel blockers, cholestyramine, cimetidine, colesevelam, colestipol, corticosteroids, estrogens, ezetimibe/simvastatin, fenofibrate, fluvastatin, gemfibrozil, heparin, isoniazid, ketoconazole, lovastatin, neomycin, niacin, niacin/lovastatin, orlistat, raloxifene, rifampin, rosuvastatin, simvastatin, thiazide diuretics, thioridazine, verapamil, or cholesterol-lowering medication.
Having one or more of the following diseases: celiac disease, chronic kidney disease, Crohn's disease, cystic fibrosis, heart disease, hyperthyroidism, liver dysfunction, primary hyperparathyroidism, tumor-induced osteomalacia, or Whipple's disease.
Values in a row without a common letter signify differences in the proportions of participants with that characteristic, p<0.05.
Data were analyzed using multifactorial ANOVA to test for effects and interactions of the independent variables (characteristic, race and gender) on serum Mg (dependent variable). NS, p≥0.05.
CD, chronic disease; DM, diabetes medication; NS, not significant; OM, other medication; SM, South Asian men; SW, South Asian women; WM, white men; WW, white women.